Pruritus & Urticaria • Drug Eruptions • Other Common Rashes

Total Page:16

File Type:pdf, Size:1020Kb

Pruritus & Urticaria • Drug Eruptions • Other Common Rashes Medical Dermatology • Pruritus & Urticaria • Drug Eruptions • Other Common Rashes • Recognize & Refer Nishit Patel, M.D. CONFLICTS OF INTEREST • No Relevant Conflicts Special Thanks to Leigh Ann Scalf, MD OBJECTIVES • Learn to diagnose and manage pruritus without a primary eruption • Diagnosis and treatment of urticaria • Identify features of common drug eruptions • Identify drug rashes that constitute dermatologic emergencies OVERVIEW Pruritus = “Itching” Urticaria = “Hives” PRURITUS WITHOUT PRIMARY LESIONS In other words…”just itching and scratching.” So, now what?? COMMON PRESENTATION Butterfly area over scapulae often spared because the patient cannot reach the area to scratch. Beware: some patients are very flexible and CAN reach this area!! “BY THE BOOK” The million dollar work-up can be found in any text book But…. PRACTICAL PRURITUS WORK UP CBC (anemia) LFT (Hepatic dysfunction) BUN/Cr (Renal dysfunction) TSH (Hypothyroidism) ANA (Lupus) CXR (Cancer) All “age appropriate” cancer screenings Get a complete “ROS” URTICARIA GROUPING OF URTICARIA • Acute Urticaria (<6 wks) • Chronic Urticaria (>6 wks) • Cause • Cause • 50% idiopathic/unknown • 60% - idiopathic/unknown, • 40% Upper respiratory tract autoimmune, infection related infections • 35% physical urticaria • 9% drug reaction • 5% urticarial vasculitis • 1% food related • Prognosis – 50% of patients with • Prognosis – Excellent, usually resolves chronic urticaria will resolve in 1 year. within days to weeks Can be very difficult to manage. URTICARIA / ANGIOEDEMA Pruritic wheals Individual lesions disappear within 24 hours. DERMATOGRAPHISM https://upload.wikimedia.org/wikipedia/commons/thumb/4/42/Dermatographic_urticaria.jpg/1200px- Dermatographic_urticaria.jpg URTICARIA / ANGIOEDEMA May be associated with: Angioedema Anaphylaxis with bronchospasm, laryngospasm, or hypotension URTICARIA / ANGIOEDEMA If the patient gives a history of anaphylaxis (throat swelling, difficulty breathing): Give Rx for Epi-Pen (Twin Ject) and “Emergency Plan” Refer to Allergist URTICARIA / ANGIOEDEMA Immunologic Most commonly associated with penicillin and beta- lactam antibiotics Nonimmunologic Aspirin and NSAIDS are the most common causes. Also caused by radiocontrast. (*Pre-testing does NOT exclude the possibility of an anaphylactoid reaction to radiocontrast.) URTICARIA / ANGIOEDEMA ACE inhibitors can cause angioedema African Americans at nearly 5 times greater risk than caucasians Lisinopril and enalapril > captopril Blockade of kininase II by ACE inhibitors may increase the tissue kinin levels, thus enhancing urticarial reactions and angioedema. OTHER “URTICARIAS” • Physical Urticaria • Urticarial Vasculitis “EMPHASIS ON TREATMENT…” URTICARIA • Anti-Histamines (non/low-sedating), over-the-counter • Loratidine (Claritin), Cetirizine (Zyrtec), Fexofenadine (Allegra), Levocetirizine (Xyzal) • Anti-Histamines (non/low-sedating), prescription only • Desloratidine (Clarinex) 5mg daily (AM or PM) • Anti-Histamines (sedating, use at night only) • Diaphenhydramine (Benadryl) 25mg (at bedtime) • *Hydroxyzine (Atarax) 10mg/25mg/50mg (at bedtime) • *Doxepin 10mg/25mg (at bedtime) • Additional Tx Considerations: • *Anti-Histamines (H2- Blockers), Prednison, *Montelukast (Singulair), Omalizumab (Xolair) * off label usage EMPHASIZE TRIGGER AVOIDANCE • Avoid NSAIDs (non-steroidal anti-inflammatory medications Aspirin, Ibuprofen (Motrin), Aleve (naproxen), Meloxicam, Celebrex, etc. • Avoid triggers of mast-cell degranulation (histamine release) • Medications = Opioids (narcotic pain medications), contrast dyes (radiology imaging), anticholinergic medications, polymyxin B sulfate ( in topical antibiotics) • Heat/friction • Alcohol OTHER WORKUP TO CONSIDER • CBC • C3, C4 • CMP • C1-Inh (qualitative/quantitative) • ESR • • ANA C1q • • TSH Anti-C1q • CH50 • IgE PEARLS 1) Pruritus without primary lesions should be worked up to rule out any underlying etiology. 2) Urticaria: Individual lesions disappear within 24 hours. 3) Immunologic urticaria: Most commonly associated with penicillin and beta-lactam antibiotics 4) Non-immunologic urticaria: Aspirin and NSAIDS are the most common causes. 5) Antihistamines are the mainstay of treatment for urticaria. Drug Eruptions DRUG ERUPTIONS, OVERVIEW Extremely diverse Almost any drug may be capable of producing a reaction. A certain drug may also cause several different reaction patterns in different patients. IN GENERAL… DRUG ERUPTIONS Most occur within days to weeks after beginning the offending agent Occasionally a reaction begins after long-term use of a particular drug **MORBILLIFORM (AKA: EXANTHEM-LIKE, MACULAR AND PAPULAR, SCARLETINIFORM) ERUPTIONS ARE THE MOST FREQUENT OF ALL CUTANEOUS REACTIONS TO DRUGS EXANTHEMS “MORBILLIFORM” OR “SCARLETINIFORM” REACTIONS Pruritus common Usually occur with in first 2 weeks of treatment Usually start proximally (groin/axillae), then generalize within 1-2 days PATHOGENESIS NON-IMMUNOLOGIC IMMUNOLOGIC *Drug reactions : -not simply drug allergy -may result from variations in drug metabolism, immune status, coexistent diseases, and other co-administered medications. EXANTHEM-LIKE ERUPTIONS Most common culprits: Penicillins Cephalosporins Sulfonamides Carbamazepine Hydantoins Allopurinol Gold “EMPHASIS ON TREATMENT…” “Simple exanthems” (skin only!) Supportive care stop offending med, topical steroids, antihistamines FIXED DRUG ERUPTION FIXED DRUG ERUPTION Adverse reaction to an ingested drug Usually solitary Plaque, bulla, or erosion Upon rechallenge, FDE occurs at identical site within hours of ingestion FIXED DRUG ERUPTION Usually asymptomatic May be pruritic or burning Painful if eroded Post-inflammatory pigmentary alteration (PIPA) remains between flares – usually hyperpigmentation. MOST COMMONLY IMPLICATED DRUGS: Phenolphthalein Antimicrobials Tetracyclines Sulfonamides Psychoactive agents Anti-inflammatory agents OCPs Quinine Pseudoephedrine (Sudafed) FIXED DRUG ERUPTION Treatment: identify and stop offending drug Non-eroded: potent topical steroid Eroded: bacitracin or silvadene PIPA (dermal melanin) does NOT respond to hydroquinone therapy GOOD RASH GONE BAD! Occasionally, exanthem-like eruptions are associated with: Interstitial nephritis Hepatitis Lymphadenopathy So, don’t forget to do a thorough history and physical! “GOOD RASH” PEARLS 1) Drug reactions are DIVERSE. 2) Certain drugs are more likely to produce certain reactions. 3) The most common drug reaction is a moribilliform eruption. 4) Simple “skin-only” exanthems require supportive care…stop offending medication, topical steroids, antihistamines. 5) There can be systemic involvement. *Do a thorough history and physical!! 6) Fixed drug eruptions recur in the same location upon re- exposure to the offending agent OTHER COMMON RASHES Image from: https://www.merckmanuals.com/-/media/manual/professional/images/4812-pityriasis-rosea-herald-patch-public- health-image-library-high.jpg?la=en&thn=0 PITYRIASIS ROSEA • A self-limited papulosquamous eruption that is occasionally pruritic • Seen mainly in adolescents and young adults, favoring the trunk and proximal extremities • Individual lesions are usually oval in shape and their long axis is oriented along the lines of cleavage • Less common variants include inverse, vesicular, purpuric and pustular PITYRIASIS ROSEA Pathogenesis ? Viral etiology Focus on human herpesvirus-7 (HHV-7) and, less so, on HHV-6 Some studies have shown no difference in prevalence of DNA from HHV-6 or HHV-7 in pts w PR Support for viral etiology: prodromal symptoms experienced by some, clustering of cases, and almost complete absence of recurrent episodes, suggesting immunologic defense against infectious agent Epidemiology Female > male Affects otherwise healthy adolescents and young adults Typical eruption lasts 6-8 weeks, then resolves spontaneously May occasionally last > 5 months ? Slight seasonal variation PITYRIASIS ROSEA - CLINICAL “Herald Patch” Large skin- to pink- to salmon-colored patch or plaque with slightly raised advancing margin Center – fine scaling (like other lesions) Margin - larger, more obvious trailing collarette of scale with the free edge pointing inwards Often on trunk, precedes other lesions by hours to days Seen in ~50% of cases ~5% of pts experience a mild prodrome PITYRIASIS ROSEA - CLINICAL Other lesions Similar to herald patch but smaller Rapidly appear, usually on trunk and proximal extremities Long axis following Langer's lines of cleavage “Christmas tree” pattern on back More papular and hyperpigmented in pts w/ skin of color May be pustular initially Face, palms and soles usually spared PITYRIASIS ROSEA - CLINICAL Pruritus in ~25% of pts Atypical forms of pityriasis rosea Inverse - axillae and inguinal areas; sometimes the face More common in younger children and in those with darkly pigmented skin Other: urticarial, erythema multiforme- like, vesicular, pustular and purpuric variants PITYRIASIS ROSEA - CLINICAL Treatment Patient education and reassurance Pruritis Counterirritant antipruritic lotions Low- to medium-strength topical corticosteroids Severe cases UVB – reduces severity of PR but not duration or pruritus Antihistamines Short course oral steroids ERYTHEMA ANNULARE CENTRIFUGUM (EAC) • Erythema Annulare Centrifugum (EAC) • Applies to a broad spectrum of clinical findings, “default” diagnosis • Peak age: 40s • No known gender difference • Can last days-decades • Possibly represents a reaction pattern or hypersensitivity to one of many
Recommended publications
  • 3628-3641-Pruritus in Selected Dermatoses
    Eur opean Rev iew for Med ical and Pharmacol ogical Sci ences 2016; 20: 3628-3641 Pruritus in selected dermatoses K. OLEK-HRAB 1, M. HRAB 2, J. SZYFTER-HARRIS 1, Z. ADAMSKI 1 1Department of Dermatology, University of Medical Sciences, Poznan, Poland 2Department of Urology, University of Medical Sciences, Poznan, Poland Abstract. – Pruritus is a natural defence mech - logical self-defence mechanism similar to other anism of the body and creates the scratch reflex skin sensations, such as touch, pain, vibration, as a defensive reaction to potentially dangerous cold or heat, enabling the protection of the skin environmental factors. Together with pain, pruritus from external factors. Pruritus is a frequent is a type of superficial sensory experience. Pruri - symptom associated with dermatoses and various tus is a symptom often experienced both in 1 healthy subjects and in those who have symptoms systemic diseases . Acute pruritus often develops of a disease. In dermatology, pruritus is a frequent simultaneously with urticarial symptoms or as an symptom associated with a number of dermatoses acute undesirable reaction to drugs. The treat - and is sometimes an auxiliary factor in the diag - ment of this form of pruritus is much easier. nostic process. Apart from histamine, the most The chronic pruritus that often develops in pa - popular pruritus mediators include tryptase, en - tients with cholestasis, kidney diseases or skin dothelins, substance P, bradykinin, prostaglandins diseases (e.g. atopic dermatitis) is often more dif - and acetylcholine. The group of atopic diseases is 2,3 characterized by the presence of very persistent ficult to treat . Persistent rubbing, scratching or pruritus.
    [Show full text]
  • Skin Manifestation of SARS-Cov-2: the Italian Experience
    Journal of Clinical Medicine Article Skin Manifestation of SARS-CoV-2: The Italian Experience Gerardo Cazzato 1 , Caterina Foti 2, Anna Colagrande 1, Antonietta Cimmino 1, Sara Scarcella 1, Gerolamo Cicco 1, Sara Sablone 3, Francesca Arezzo 4, Paolo Romita 2, Teresa Lettini 1 , Leonardo Resta 1 and Giuseppe Ingravallo 1,* 1 Section of Pathology, University of Bari ‘Aldo Moro’, 70121 Bari, Italy; [email protected] (G.C.); [email protected] (A.C.); [email protected] (A.C.); [email protected] (S.S.); [email protected] (G.C.); [email protected] (T.L.); [email protected] (L.R.) 2 Section of Dermatology and Venereology, University of Bari ‘Aldo Moro’, 70121 Bari, Italy; [email protected] (C.F.); [email protected] (P.R.) 3 Section of Forensic Medicine, University of Bari ‘Aldo Moro’, 70121 Bari, Italy; [email protected] 4 Section of Gynecologic and Obstetrics Clinic, University of Bari ‘Aldo Moro’, 70121 Bari, Italy; [email protected] * Correspondence: [email protected] Abstract: At the end of December 2019, a new coronavirus denominated Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was identified in Wuhan, Hubei province, China. Less than three months later, the World Health Organization (WHO) declared coronavirus disease-19 (COVID-19) to be a global pandemic. Growing numbers of clinical, histopathological, and molecular findings were subsequently reported, among which a particular interest in skin manifestations during the course of the disease was evinced. Today, about one year after the development of the first major infectious foci in Italy, various large case series of patients with COVID-19-related skin Citation: Cazzato, G.; Foti, C.; manifestations have focused on skin specimens.
    [Show full text]
  • Shingles (Herpes Zoster) Hives (Urticaria) Psoriasis
    Shingles (Herpes Zoster) Shingles starts with burning, tingling, or very sensitive skin. A rash of raised dots develops into painful blisters that last about two weeks. Shingles often occurs on the trunk and buttocks, but can appear anywhere. Most people recover, but pain, numbness, and itching linger for many -- and may last for months, years, or the rest of their lives. Treatment with antiviral drugs, steroids, antidepressants, and topical agents can help. Hives (Urticaria) A common allergic reaction that looks like welts, hives are often itchy, and sometimes stinging or burning. Hives vary in size and may join together to form larger areas. They may appear anywhere and last minutes or days. Medications, foods, food additives, temperature extremes, and infections like strep throat are some causes of hives. Antihistamines can provide relief. Psoriasis A non-contagious rash of thick red plaques covered with white or silvery scales, psoriasis usually affects the scalp, elbows, knees, and lower back. The rash can heal and recur throughout life. The cause of psoriasis is unknown, but the immune system triggers new skin cells to develop too quickly. Treatments include medications applied to the skin, light therapy, and medications taken by mouth, injection or infusion. Eczema Eczema describes several non-contagious conditions where skin is inflamed, red, dry, and itchy. Stress, irritants (like soaps), allergens, and climate can trigger flare-ups though they're not eczema's exact cause, which is unknown. In adults, eczema often occurs on the elbows and hands, and in "bending" areas, such as inside the elbows. Treatments include topical or oral medications and shots.
    [Show full text]
  • BETA Betamethasone Valerate Cream 0.1% W/W Betamethasone Valerate Ointment 0.1% W/W
    NEW ZEALAND CONSUMER MEDICINE INFORMATION BETA Betamethasone valerate cream 0.1% w/w Betamethasone valerate ointment 0.1% w/w discoid lupus Some of the symptoms of an What is in this leaflet erythematosus (recurring allergic reaction may include: scaly rash) shortness of breath; wheezing or This leaflet answers some common prickly heat skin reaction difficulty breathing; swelling of the questions about BETA Cream and insect bite reactions face, lips, tongue or other parts of Ointment. prurigo nodularis (an itching the body; rash, itching or hives on and thickening of the skin the skin. It does not contain all the available with lumps or nodules) information. It does not take the contact sensitivity reactions Do not use BETA Cream or place of talking to your doctor or an additional treatment for Ointment to treat any of the pharmacist. an intense widespread following skin problems as it reddening and inflammation could make them worse: All medicines have risks and of the skin, infected skin (unless the benefits. Your doctor has weighed when milder topical corticosteroids infection is being treated the risks of you using BETA Cream cannot treat the skin condition with an anti-infective or Ointment against the benefits effectively. medicine at the same time) they expect it will have for you. acne BETA Cream is usually used to rosacea (a facial skin If you have any concerns about treat skin conditions on moist condition where the nose, taking this medicine, ask your surfaces; BETA Ointment is usually cheeks, chin, forehead or doctor or pharmacist. used to treat skin conditions on dry, entire face are unusually scaly skin.
    [Show full text]
  • Erythema Annulare Centrifugum ▪ Erythema Gyratum Repens ▪ Exfoliative Erythroderma Urticaria ▪ COMMON: 15% All Americans
    Cutaneous Signs of Internal Malignancy Ted Rosen, MD Professor of Dermatology Baylor College of Medicine Disclosure/Conflict of Interest ▪ No relevant disclosures ▪ No conflicts of interest Objectives ▪ Recognize common disorders associated with internal malignancy ▪ Manage cutaneous disorders in the context of associated internal malignancy ▪ Differentiate cutaneous signs of leukemia and lymphoma ▪ Understand spidemiology of cutaneous metastases Cutaneous Signs of Internal Malignancy ▪ General physical examination ▪ Pallor (anemia) ▪ Jaundice (hepatic or cholestatic disease) ▪ Fixed erythema or flushing (carcinoid) ▪ Alopecia (diffuse metastatic disease) ▪ Itching (excoriations) Anemia: Conjunctival pallor and Pale skin Jaundice 1-12% of hepatocellular, biliary tree or pancreatic cancer PRESENT with jaundice, but up to 40-60% eventually develop it World J Gastroenterol 2003;9:385-91 For comparison CAN YOU TELL JAUNDICE FROM NORMAL SKIN? JAUNDICE Alopecia Neoplastica Most common report w/ breast CA Lung, cervix, desmoplastic mm Hair loss w/ underlying induration Biopsy = dermis effaced by tumor Ann Dermatol 26:624, 2014 South Med J 102:385, 2009 Int J Dermatol 46:188, 2007 Acta Derm Venereol 87:93, 2007 J Eur Acad Derm Venereol 18:708, 2004 Gastric Adenocarcinoma: Alopecia Ann Dermatol 2014; 26: 624–627 Pruritus: Excoriation ▪ Overall risk internal malignancy presenting as itch LOW. OR =1.14 ▪ CTCL, Hodgkin’s & NHL, Polycythemia vera ▪ Biliary tree carcinoma Eur J Pain 20:19-23, 2016 Br J Dermatol 171:839-46, 2014 J Am Acad Dermatol 70:651-8, 2014 Non-specific (Paraneoplastic) Specific (Metastatic Disease) Paraneoplastic Signs “Curth’s Postulates” ▪ Concurrent onset (temporal proximity) ▪ Parallel course ▪ Uniform site or type of neoplasm ▪ Statistical association ▪ Genetic linkage (syndromal) Curth HO.
    [Show full text]
  • Drug Eruptions.Pdf
    Drug eruptions & reactions What are drug eruptions? Drug reactions are unwanted and unexpected reactions occurring in the skin (and sometimes other organ systems) that may result from taking a medication for the prevention, diagnosis or treatment of a medical problem. They may appear after the correct use of the medication or drug. It may also appear due to overdose (wrong dose is taken), following accumulation of drugs in the body over time, or by interactions with other medications being taken or used by the person. Drug eruptions could be caused by an allergy or hypersensitivity to the drug, by a direct toxic effect of the drug or medication on the skin, or by other mechanisms. Drug eruptions vary in severity – from a minor nuisance to a more severe problem – and may even cause death. Drug eruptions occur in up to 15% of courses of drug prescribed by medical or natural therapy practitioners. What causes drug eruptions? Drug eruptions are caused by medications which are prescribed by your doctor, purchased over-the- counter or purchased as compounded herbal/naturopathic medicines. Drugs taken orally, injected, delivered by patch application, rubbed onto the skin (e.g. creams, ointments and lotions) can all cause reactions. The potential to develop an adverse reaction to a drug is influenced by the age, gender and genetic makeup of the person; the nature of the condition being treated; and the possible interactions with other medications being taken. Some classes of drugs are known to cause drug eruptions more commonly than others. What do drug eruptions look like in the skin? The appearance of drug eruptions varies depending on the mechanism of the drug reaction.
    [Show full text]
  • Etiology, Classification, and Treatment of Urticaria
    CONTINUING MEDICAL EDUCATION Etiology, Classification, and Treatment of Urticaria Kjetil Kristoffer Guldbakke, MD; Amor Khachemoune, MD, CWS GOAL To understand urticaria to better manage patients with the condition OBJECTIVES Upon completion of this activity, dermatologists and general practitioners should be able to: 1. Discuss the clinical classification of urticaria. 2. Recognize how to diagnose urticaria. 3. Identify treatment options. CME Test on page 50. This article has been peer reviewed and approved Einstein College of Medicine is accredited by by Michael Fisher, MD, Professor of Medicine, the ACCME to provide continuing medical edu- Albert Einstein College of Medicine. Review date: cation for physicians. December 2006. Albert Einstein College of Medicine designates This activity has been planned and imple- this educational activity for a maximum of 1 AMA mented in accordance with the Essential Areas PRA Category 1 CreditTM. Physicians should only and Policies of the Accreditation Council for claim credit commensurate with the extent of their Continuing Medical Education through the participation in the activity. joint sponsorship of Albert Einstein College of This activity has been planned and produced in Medicine and Quadrant HealthCom, Inc. Albert accordance with ACCME Essentials. Drs. Guldbakke and Khachemoune report no conflict of interest. The authors discuss off-label use of colchi- cine, cyclophosphamide, cyclosporine, dapsone, intravenous immunoglobulin, methotrexate, montelukast sodium, nifedipine, plasmapheresis, rofecoxib, sulfasalazine, tacrolimus, thyroxine, and zafirlukast. Dr. Fisher reports no conflict of interest. Urticaria is among the most common skin dis- autoimmune mechanisms are now recognized as a eases. It can be acute, chronic, mediated by a cause of chronic urticaria. A search of the PubMed physical stimulus, or related to contact with an database (US National Library of Medicine) for urticant.
    [Show full text]
  • Antihistamines in the Treatment of Chronic Urticaria I Jáuregui,1 M Ferrer,2 J Montoro,3 I Dávila,4 J Bartra,5 a Del Cuvillo,6 J Mullol,7 J Sastre,8 a Valero5
    Antihistamines in the treatment of chronic urticaria I Jáuregui,1 M Ferrer,2 J Montoro,3 I Dávila,4 J Bartra,5 A del Cuvillo,6 J Mullol,7 J Sastre,8 A Valero5 1 Service of Allergy, Hospital de Basurto, Bilbao, Spain 2 Department of Allergology, Clínica Universitaria de Navarra, Pamplona, Spain 3 Allergy Unit, Hospital La Plana, Villarreal (Castellón), Spain 4 Service of Immunoallergy, Hospital Clínico, Salamanca, Spain 5 Allergy Unit, Service of Pneumology and Respiratory Allergy, Hospital Clínic (ICT), Barcelona, Spain 6 Clínica Dr. Lobatón, Cádiz, Spain 7 Rhinology Unit, ENT Service (ICEMEQ), Hospital Clínic, Barcelona, Spain 8 Service of Allergy, Fundación Jiménez Díaz, Madrid, Spain ■ Summary Chronic urticaria is highly prevalent in the general population, and while there are multiple treatments for the disorder, the results obtained are not completely satisfactory. The second-generation H1 antihistamines remain the symptomatic treatment option of choice. Depending on the different pharmacokinetics and H1 receptor affi nity of each drug substance, different concentrations in skin can be expected, together with different effi cacy in relation to the histamine-induced wheal inhibition test - though this does not necessarily have repercussions upon clinical response. The antiinfl ammatory properties of the H1 antihistamines could be of relevance in chronic urticaria, though it is not clear to what degree they infl uence the fi nal therapeutic result. Before moving on to another therapeutic level, the advisability of antihistamine dose escalation should be considered, involving increments even above those approved in the Summary of Product Characteristics. Physical urticaria, when manifesting isolatedly, tends to respond well to H1 antihistamines, with the exception of genuine solar urticaria and delayed pressure urticaria.
    [Show full text]
  • 10 Chronic Urticaria As an Autoimmune Disease
    10 Chronic Urticaria as an Autoimmune Disease Michihiro Hide, Malcolm W. Greaves Introduction Urticaria is conventionally classified as acute, intermittent and chronic (Grea- ves 2000a). Acute urticaria which frequently involves an IgE-mediated im- munological mechanism, is common, its causes often recognised by the patient, and will not be considered further. Intermittent urticaria – frequent bouts of unexplained urticaria at intervals of weeks or months – will be dis- cussed here on the same basis as ‘ordinary’ chronic urticaria. The latter is conventionally defined as the occurrence of daily or almost daily whealing for at least six weeks. The etiology of chronic urticaria is usually obscure. The different clinical varieties of chronic urticaria will be briefly considered here, and attention will be devoted to a newly emerged entity – autoimmune chronic urticaria, since establishing this diagnosis has conceptual, prognostic and the- rapeutic implications. Contact urticaria and angioedema without urticaria will not be dealt with in this account. Classification of Chronic Urticaria The clinical subtypes of chronic urticaria are illustrated in the pie-chart of Fig. 1. The frequency of these subtypes is based upon the authors’ experience at the St John’s Institute of Dermatology in UK. Whilst there may well be mi- nor differences, it is likely that the frequency distribution of these subtypes will be essentially similar in most centres in Europe and North America (Grea- ves 1995, 2000b). However, our experience suggests that the incidence of angioedema, especially that complicated by ordinary chronic urticaria is sub- stantially lower in Japan and south Asian countries (unpublished observation). 310 Michihiro Hide and Malcolm W.
    [Show full text]
  • Urticaria and Angioedema
    Urticaria and Angioedema This guideline, developed by Robbie Pesek, MD and Allison Burbank, MD, in collaboration with the ANGELS team, on July 23, 2013, is a significantly revised version of the guideline originally developed by Jeremy Bufford, MD. Last reviewed by Robbie Pesek, MD September 14, 2016. Key Points Urticaria and angioedema are common problems and can be caused by both allergic and non- allergic mechanisms. Prompt diagnosis of hereditary angioedema (HAE) is important to prevent morbidity and mortality. Several new therapeutic options are now available. Patients with urticaria and/or angioedema should be referred to an allergist/immunologist for symptoms that are difficult to control, suspicion of HAE, or to rule out suspected allergic triggers. Definition, Assessment, and Diagnosis Definitions Urticaria is a superficial skin reaction consisting of erythematous, raised, blanching, well- circumscribed or confluent pruritic, edematous wheals, often with reflex erythema.1-3 Urticarial lesions are typically pruritic, and wax/wane with resolution of individual lesions within 24 hours. Angioedema is localized swelling of deep dermal, subcutaneous, or submucosal tissue resulting from similar vascular changes that contribute to urticaria.1,2 Angioedema may be pruritic and/or painful and can last for 2-3 days depending on etiology.3 1 Urticaria alone occurs in 50% of patients and is associated with angioedema in 40% of patients. Isolated angioedema occurs in 10% of patients.1,2 Hereditary angioedema (HAE) is a disorder involving defects in complement, coagulation, kinin, and fibrinolytic pathways that results in recurrent episodes of angioedema without urticaria, usually affecting the skin, upper airway, and gastrointestinal tract.4 In children, acute urticaria is more common than chronic forms.
    [Show full text]
  • Itching to Know More About Eczema and Ectodermal Dysplasia
    ITCHING TO KNOW MORE ABOUT ECZEMA AND ECTODERMAL DYSPLASIA Eczema, sometimes called dermatitis, is inflammation of the skin that can lead to an itchy rash. There are many different types of eczema, but the most common kind of eczema is atopic dermatitis. When people refer to eczema, they are typically referring to atopic dermatitis. This condition affects up to 20% of people worldwide, particularly infants and children. Individuals with ectodermal dysplasia, especially hypohidrotic ectodermal dysplasia (HED), are affected even more commonly than the general population with up to 50% having atopic dermatitis. The exact cause of atopic seasonal allergies, asthma or and on the neck and face. dermatitis is unknown. But, eczema. As the rash becomes more there are many factors that established, the dry skin may make a person prone to this Rarely, atopic dermatitis may be become thickened, leathery, and type of rash. We know the related to food sensitivity, but sometimes darker in coloration main issue in eczema is that this is actually quite rare as food due to repetitive rubbing and the skin barrier that holds in allergies typically cause hives scratching. moisture and protects us is not and not eczema. In the majority functioning optimally. This is of cases, no allergic triggers When the rash improves, the case even in those without can be found. Therefore, allergy the skin may appear lighter ectodermal dysplasia, but the testing in most cases is not for some time, especially in poorly developed sweat and necessary or helpful in treating a the summer months but this oil glands likely affect the skin person’s eczema.
    [Show full text]
  • Urticaria and Angioedema
    URTICARIA AND ANGIOEDEMA What are the aims of this leaflet? This leaflet has been written to help you understand more about urticaria and angioedema. It tells you what they are, what causes them, what you can do about them, and where you can find out more about them. What is urticaria and angioedema? Urticaria is common, and affects about 20% of people at some point in their lives. It is also known as hives or nettle rash. The short-lived swellings of urticaria are known as weals (see below) and typically any individual spot will clear within 24 hours although the overall rash may last for longer. Angioedema is a form of urticaria in which there is deeper swelling in the skin, and the swelling may take longer than 24 hours to clear. An affected individual may have urticaria alone, angioedema alone, or both together. Both are caused by the release of histamine from cells in the skin called mast cells. When angioedema occurs in association with urticaria, the two conditions can be considered part of the same process. When angioedema occurs on its own, different causes need to be considered. There are different types of urticaria of which the most common form is called ‘ordinary or idiopathic urticaria’. In this type no cause is usually identified and often patients have hives and angioedema occurring together. Ordinary urticaria with or without angioedema is usually divided into ‘acute’ and ‘chronic’ forms. In ‘acute’ urticaria/angioedema, the episode lasts from a few days up to six weeks. Chronic urticaria, by definition, lasts for more than six weeks.
    [Show full text]